Click for best price
Somatuline Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 1321.4 million
|
Forecast Market size by 2030 |
US$ 1430.1 million
|
| Growth Rate |
CAGR of 1.2% |
Number of Pages |
84 Pages |
This research report provides a comprehensive analysis of the Somatuline Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Somatuline Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Somatuline Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Somatuline Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Somatuline Drugs market presents opportunities for various stakeholders, including Hospital, Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Somatuline Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Somatuline Drugs market was valued at US$ 1321.4 million in 2023 and is projected to reach US$ 1430.1 million by 2030, at a CAGR of 1.2% during the forecast period.
Lanreotide is a somatostatin analog primarily used to treat acromegaly and neuroendocrine tumors. Its efficacy in controlling hormone secretion and tumor growth has driven market growth. The rising prevalence of acromegaly and neuroendocrine tumors, coupled with the drug's extended duration of action, contributes to its popularity. However, competition from other somatostatin analogs and the need for individualized treatment plans may pose challenges. The market is relatively small compared to other therapeutic areas. Despite challenges, the Lanreotide market presents potential for expansion as healthcare providers prioritize personalized and targeted therapies for acromegaly and neuroendocrine tumors, creating opportunities for further development and investment.
Key Features:
The research report on the Somatuline Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Somatuline Drugs market.
Market Overview: The report provides a comprehensive overview of the Somatuline Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 60 mg, 90 mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Somatuline Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Somatuline Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Somatuline Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Somatuline Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Somatuline Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Somatuline Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Somatuline Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Somatuline Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Somatuline Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Market segment by Application
Global Somatuline Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
Outline of Major Chapters:
Chapter 1: Introduces the definition of Somatuline Drugs, market overview.
Chapter 2: Global Somatuline Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Somatuline Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Somatuline Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Somatuline Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Somatuline Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 1321.4 million
|
| Forecast Market size by 2030 |
US$ 1430.1 million
|
| Growth Rate |
CAGR of 1.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
84 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Somatuline Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Somatuline Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Somatuline Drugs Overall Market Size
2.1 Global Somatuline Drugs Market Size: 2023 VS 2030
2.2 Global Somatuline Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Somatuline Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Somatuline Drugs Players in Global Market
3.2 Top Global Somatuline Drugs Companies Ranked by Revenue
3.3 Global Somatuline Drugs Revenue by Companies
3.4 Global Somatuline Drugs Sales by Companies
3.5 Global Somatuline Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Somatuline Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Somatuline Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Somatuline Drugs Players in Global Market
3.8.1 List of Global Tier 1 Somatuline Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Somatuline Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Somatuline Drugs Market Size Markets, 2023 & 2030
4.1.2 60 mg
4.1.3 90 mg
4.1.4 120 mg
4.2 By Type - Global Somatuline Drugs Revenue & Forecasts
4.2.1 By Type - Global Somatuline Drugs Revenue, 2019-2024
4.2.2 By Type - Global Somatuline Drugs Revenue, 2025-2030
4.2.3 By Type - Global Somatuline Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Somatuline Drugs Sales & Forecasts
4.3.1 By Type - Global Somatuline Drugs Sales, 2019-2024
4.3.2 By Type - Global Somatuline Drugs Sales, 2025-2030
4.3.3 By Type - Global Somatuline Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Somatuline Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Somatuline Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Somatuline Drugs Revenue & Forecasts
5.2.1 By Application - Global Somatuline Drugs Revenue, 2019-2024
5.2.2 By Application - Global Somatuline Drugs Revenue, 2025-2030
5.2.3 By Application - Global Somatuline Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Somatuline Drugs Sales & Forecasts
5.3.1 By Application - Global Somatuline Drugs Sales, 2019-2024
5.3.2 By Application - Global Somatuline Drugs Sales, 2025-2030
5.3.3 By Application - Global Somatuline Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Somatuline Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Somatuline Drugs Market Size, 2023 & 2030
6.2 By Region - Global Somatuline Drugs Revenue & Forecasts
6.2.1 By Region - Global Somatuline Drugs Revenue, 2019-2024
6.2.2 By Region - Global Somatuline Drugs Revenue, 2025-2030
6.2.3 By Region - Global Somatuline Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Somatuline Drugs Sales & Forecasts
6.3.1 By Region - Global Somatuline Drugs Sales, 2019-2024
6.3.2 By Region - Global Somatuline Drugs Sales, 2025-2030
6.3.3 By Region - Global Somatuline Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Somatuline Drugs Revenue, 2019-2030
6.4.2 By Country - North America Somatuline Drugs Sales, 2019-2030
6.4.3 US Somatuline Drugs Market Size, 2019-2030
6.4.4 Canada Somatuline Drugs Market Size, 2019-2030
6.4.5 Mexico Somatuline Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Somatuline Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Somatuline Drugs Sales, 2019-2030
6.5.3 Germany Somatuline Drugs Market Size, 2019-2030
6.5.4 France Somatuline Drugs Market Size, 2019-2030
6.5.5 U.K. Somatuline Drugs Market Size, 2019-2030
6.5.6 Italy Somatuline Drugs Market Size, 2019-2030
6.5.7 Russia Somatuline Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Somatuline Drugs Market Size, 2019-2030
6.5.9 Benelux Somatuline Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Somatuline Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Somatuline Drugs Sales, 2019-2030
6.6.3 China Somatuline Drugs Market Size, 2019-2030
6.6.4 Japan Somatuline Drugs Market Size, 2019-2030
6.6.5 South Korea Somatuline Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Somatuline Drugs Market Size, 2019-2030
6.6.7 India Somatuline Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Somatuline Drugs Revenue, 2019-2030
6.7.2 By Country - South America Somatuline Drugs Sales, 2019-2030
6.7.3 Brazil Somatuline Drugs Market Size, 2019-2030
6.7.4 Argentina Somatuline Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Somatuline Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Somatuline Drugs Sales, 2019-2030
6.8.3 Turkey Somatuline Drugs Market Size, 2019-2030
6.8.4 Israel Somatuline Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Somatuline Drugs Market Size, 2019-2030
6.8.6 UAE Somatuline Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 IPSEN
7.1.1 IPSEN Company Summary
7.1.2 IPSEN Business Overview
7.1.3 IPSEN Somatuline Drugs Major Product Offerings
7.1.4 IPSEN Somatuline Drugs Sales and Revenue in Global (2019-2024)
7.1.5 IPSEN Key News & Latest Developments
8 Global Somatuline Drugs Production Capacity, Analysis
8.1 Global Somatuline Drugs Production Capacity, 2019-2030
8.2 Somatuline Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Somatuline Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Somatuline Drugs Supply Chain Analysis
10.1 Somatuline Drugs Industry Value Chain
10.2 Somatuline Drugs Upstream Market
10.3 Somatuline Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Somatuline Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Somatuline Drugs in Global Market
Table 2. Top Somatuline Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Somatuline Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Somatuline Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Somatuline Drugs Sales by Companies, (Units), 2019-2024
Table 6. Global Somatuline Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Somatuline Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Somatuline Drugs Product Type
Table 9. List of Global Tier 1 Somatuline Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Somatuline Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Somatuline Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Somatuline Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Somatuline Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Somatuline Drugs Sales (Units), 2019-2024
Table 15. By Type - Global Somatuline Drugs Sales (Units), 2025-2030
Table 16. By Application ? Global Somatuline Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Somatuline Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Somatuline Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Somatuline Drugs Sales (Units), 2019-2024
Table 20. By Application - Global Somatuline Drugs Sales (Units), 2025-2030
Table 21. By Region ? Global Somatuline Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Somatuline Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Somatuline Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Somatuline Drugs Sales (Units), 2019-2024
Table 25. By Region - Global Somatuline Drugs Sales (Units), 2025-2030
Table 26. By Country - North America Somatuline Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Somatuline Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Somatuline Drugs Sales, (Units), 2019-2024
Table 29. By Country - North America Somatuline Drugs Sales, (Units), 2025-2030
Table 30. By Country - Europe Somatuline Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Somatuline Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Somatuline Drugs Sales, (Units), 2019-2024
Table 33. By Country - Europe Somatuline Drugs Sales, (Units), 2025-2030
Table 34. By Region - Asia Somatuline Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Somatuline Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Somatuline Drugs Sales, (Units), 2019-2024
Table 37. By Region - Asia Somatuline Drugs Sales, (Units), 2025-2030
Table 38. By Country - South America Somatuline Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Somatuline Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Somatuline Drugs Sales, (Units), 2019-2024
Table 41. By Country - South America Somatuline Drugs Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Somatuline Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Somatuline Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Somatuline Drugs Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Somatuline Drugs Sales, (Units), 2025-2030
Table 46. IPSEN Company Summary
Table 47. IPSEN Somatuline Drugs Product Offerings
Table 48. IPSEN Somatuline Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. IPSEN Key News & Latest Developments
Table 50. Somatuline Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 51. Global Somatuline Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 52. Global Somatuline Drugs Production by Region, 2019-2024 (Units)
Table 53. Global Somatuline Drugs Production by Region, 2025-2030 (Units)
Table 54. Somatuline Drugs Market Opportunities & Trends in Global Market
Table 55. Somatuline Drugs Market Drivers in Global Market
Table 56. Somatuline Drugs Market Restraints in Global Market
Table 57. Somatuline Drugs Raw Materials
Table 58. Somatuline Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Somatuline Drugs Downstream
Table 60. Somatuline Drugs Downstream Clients in Global Market
Table 61. Somatuline Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Somatuline Drugs Segment by Type in 2023
Figure 2. Somatuline Drugs Segment by Application in 2023
Figure 3. Global Somatuline Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Somatuline Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Somatuline Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Somatuline Drugs Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Somatuline Drugs Revenue in 2023
Figure 9. By Type - Global Somatuline Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Somatuline Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Somatuline Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Somatuline Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Somatuline Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Somatuline Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Somatuline Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Somatuline Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Somatuline Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Somatuline Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Somatuline Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Somatuline Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Somatuline Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Somatuline Drugs Sales Market Share, 2019-2030
Figure 23. US Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Somatuline Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Somatuline Drugs Sales Market Share, 2019-2030
Figure 28. Germany Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Somatuline Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Somatuline Drugs Sales Market Share, 2019-2030
Figure 37. China Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Somatuline Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Somatuline Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Somatuline Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Somatuline Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Somatuline Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Somatuline Drugs Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Somatuline Drugs by Region, 2023 VS 2030
Figure 54. Somatuline Drugs Industry Value Chain
Figure 55. Marketing Channels
